Get the Stockscreener App
22.45
3.02%
-0.70
After Hours:
22.95
0.50
+2.23%
Liquidia Corp stock is traded at $22.45, with a volume of 2.77M.
It is down -3.02% in the last 24 hours and down -1.54% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$23.15
Open:
$23.3
24h Volume:
2.77M
Relative Volume:
1.03
Market Cap:
$1.93B
Revenue:
$19.32M
Net Income/Loss:
$-141.47M
P/E Ratio:
-13.32
EPS:
-1.6851
Net Cash Flow:
$-120.48M
1W Performance:
+0.49%
1M Performance:
-1.54%
6M Performance:
+66.17%
1Y Performance:
+103.35%
1-Day Range:
$22.05
$23.94
1-Week Range:
$21.94
$24.38
52-Week Range:
$9.71
$29.94
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
22.45 | 1.99B | 19.32M | -141.47M | -120.48M | -1.6851 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.21 | 108.30B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
652.91 | 69.37B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.59 | 62.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
821.97 | 51.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.95 | 34.94B | 398.11M | -1.03B | -868.57M | -5.7032 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
Has Liquidia Corporation formed a bullish divergence2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
What sentiment indicators say about Liquidia Corporation stockEarnings Overview Summary & Stock Portfolio Risk Management - newser.com
Will Liquidia Corporation (LT4) stock profit from automation waveJuly 2025 Intraday Action & Community Consensus Stock Picks - newser.com
Is Liquidia Corporation showing signs of accumulationJuly 2025 PreEarnings & Real-Time Price Movement Reports - newser.com
What dividend safety rating applies to Liquidia Corporation (LT4) stockMarket Growth Summary & Real-Time Sentiment Analysis - newser.com
Will Liquidia Corporation stock keep outperforming rivals2025 Price Targets & Safe Entry Zone Tips - newser.com
Will Liquidia Corporation stock attract more institutional investorsBuy Signal & Accurate Entry/Exit Alerts - newser.com
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 - Quiver Quantitative
How Liquidia Corporation stock performs in stagflationPortfolio Growth Summary & Intraday High Probability Setup Alerts - newser.com
Will Liquidia Corporation (LT4) stock sustain uptrend momentumEntry Point & Stepwise Trade Signal Implementation - newser.com
Does Liquidia Corporation show high probability of reboundPortfolio Update Summary & Long-Term Safe Investment Plans - newser.com
Liquidia's (LQDA) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Applying sector rotation models to Liquidia CorporationQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - newser.com
Wall Street Analysts Believe LIQUIDIA CORP (LQDA) Could Rally 50.94%: Here's is How to Trade - sharewise.com
Liquidia Corporation (LQDA) Stock Analysis: Exploring a 50.94% Potential Upside in a Booming Biotechnology Sector - DirectorsTalk Interviews
Liquidia Corp: Shares Remain Mispriced Despite Yutrepia's Exceptional Commercial Launch - Seeking Alpha
Is Liquidia Corporation (LT4) stock a top dividend aristocrat candidate2025 Top Gainers & Safe Entry Trade Reports - nchmf.gov.vn
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):